XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.31

+1.4%

Nov 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bluegreen who wrote (7126)	9/2/1998 3:56:00 PM
From: aknahow	Read Replies (3) of 17367

Yes XOMA could stop the trial on its' own without a recommendation to do so by the DSMB. This would be considered a gamble because it is blinded to the data. It would be taking a chance, that what you and I believe is correct, is worth disrupting the on going trials and acting in the face of a DSMB recommendation to continue. The benefits which we both agree on probably do not outweigh simply completing the trial as agreed to if the DSMB recommends proceeding and states there are no safety concerns. As you post, stopping the trial early when the DSMB recommends continuation would be a, "drastic measure." I do not think it would be good management to do it right, get this far and then resort to a drastic measure, or bet that they can save some money, get to market sooner and see the stock rally, by a unilateral decision to halt early. Now why does MacCamant say they will? Perhaps he has contacted some of the trial sites and is getting information that enables him to feel the DSMB will recommend an early halt. I have no such information, but I do believe that those doing the treating probably recognize something which makes them think they know who was treated.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next